11.24.2018 Issue 149

Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Jobs Round-up
Job of the Week Latest Jobs from the Jobs Portal

Associate Director, Health Economics & Outcomes Research

The Associate Director of HEOR will help drive health economics and outcomes research activities in support of products in the rare genetic disease (RGD) and hematology/oncology portfolio.

Executive Director, Health Technology Assessment (HTA) Statistics (U.S.)

Executive Director, Health Technology Assessment (HTA) Statistics (U.K.)

Health Economics and Outcomes Associate Consultant

Research Data Assistant or Research Data Coordinator-PS8373

Research Associate III- Patient-Centered Research- Hammersmith

Healthcare Software Product Manager

Health Economist

Lead Health Economist

Pfizer Announces Plans to Hike Price of 41 Drugs

Report: Patients Grapple with Synchronous Prescription Drug Price Hikes

Startup Deploys Outcomes-Based Model to Help Patients with Type 2 Diabetes

Study: Expensive Brand Drugs Driving up Prices

Industry Spotlight

Conferences Webinars
18th Annual Rx Drug Pricing Boot Camp
    November 27-30, Philadelphia, Pennsylvania

Bio/Pharma Summit on Nurse Educator Programs
    November 27, Philadelphia, Pennsylvania

Principles of Pharma Market Access in Europe
    December 4-5, Brussels, Belgium

Bio/Pharma Compliance Congress on Non-Promotional Activities
    December 4-5, Philadelphia, Pennsylvania

Mapping to Estimate Health-State Utility from Non-Preference-Based Outcome Measures
    November 27

New Requirements for Selling Devices in the European Union
    December 3

Population-based Care Management: How Health Plans Can Leverage PHM Solutions for Value-based Care (Part II)
    December 6

Intelligent Approaches to Transform Value and Access
    December 12

Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

Blockchain: Transformational Change for Pharma?

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

HTA in Europe: Key Success Factors for Positive HTA Recommendations

Transitioning Payment Models: Fee-for-Service to Value-Based Care

How Health Plans and Providers Can Collaborate to Improve Care Transitions and Reduce Hospital Readmissions

Generating Consensus and Trust for Quality Measurement to Support Value-Based Care

An Evidence-Based Approach to Hiring: Leaders, Physicians, Nurses, and Front Line Staff

Big Data in Pharmaceuticals: Big Opportunities or Big Challenges – or Both?

Health Care USA: A Cancer on the American Dream

Special Thanks to Our Partners:
            Evidera   HealthCore     University of FL
      Xcenda  OM1    Parexel   Jefferson   Dymaxium
      Precision Xtract    Pharmerit    eMax Health   Sciformix
      Evidence Partners    ICON    Truven